Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Kawasumi Laboratories expects extraordinary profit and loss and lowers full-year consolidated revenue outlook for FY 2014


Friday, 28 Mar 2014 02:00am EDT 

Kawasumi Laboratories Inc:Sees extraordinary profit of 2,600 mln yen for insurance payment received, and extraordinary loss of 2,100 mln yen for impairment loss on fixed asset, for fiscal year ending March 31, 2014.Full-year consolidated outlook for revenue of 27,600 mln yen lowered from 28,800 mln yen, for fiscal year ending March 31, 2014.Full-year operating profit outlook of 700 mln yen.Full-year ordinary profit outlook of 600 mln yen lowered from 700 mln yen.Full-year net profit outlook of 550 mln yen raised from 500 mln yen.Full-year earnings per share outlook of 24.05 yen raised from 21.86 yen.Revenue and ordinary profit outlook lowered due to decrease in sales of original equipment manufacturer (OEM) products and depreciation expense on fixed assets, and net profit outlook raised due to extraordinary profit. 

Company Quote

780.0
-3.0 -0.38%
16 Sep 2014